In this Q&A, Marie Bradley, PhD, discusses a recent study in which researchers examined how the benefit risk of apixaban and warfarin varied by age in patients aged less than 65 years with nonvalvular...
Consultant360 spoke with Amy Ushry, RN, MPH, who discussed rates of maternal morbidity and mortality and ongoing endeavors to reduce these rates at the NPWH 22nd Annual Premier Women’s Healthcare...
David G Schwartz, PhD, and Stephen Lankenau, PhD, answer our questions on the results of a study examining the effectiveness of equipping members of the community with naloxone and a smartphone application...
The COLDICE study examined the effectiveness and safety of a novel, less-invasive approach to sampling lung tissue for the diagnosis of interstitial lung disease compared with the gold-standard surgical...
Barbara Levy, MD, clinical professor of obstetrics and gynecology at The George Washington University School of Medicine, discusses the findings of a recent study on the potential for laparoscopic...
Biologic therapies have been introduced as new treatment options for patients with severe asthma. Wendy Moore, MD, answered our questions about the research she presented at CHEST2020.
Data indicates that 4 in 10 Americans have at least one tattoo. In this Q&A, board-certified dermatologist Marie Leger, MD, PhD, from Metro Dermatology in New York City, discusses potential dermatologic...
C. Prakash Gyawali, MD, MRCP, discusses the differences between conventional functional heartburn/reflux hypersensitivity (FH/RH) and FH/RH overlapping with gastroesophageal reflux disease.
Eugenia L. Siegler, MD, answers our questions about her approach to managing older adults with HIV, the challenges she and the older population face, and how to overcome those challenges.
